RESEARCH QUESTION: What are the updated outcomes and trends regarding assisted reproductive technology (ART) for single and coupled male intended parents (SCMIP) undergoing family building? DESIGN: A retrospective analysis was performed at a single, academically affiliated infertility centre in the USA from 2014 to 2023. SCMIP that underwent an initial consultation, or initiated treatment with oocyte donation and/or embryo transfer via a gestational carrier were included. Demographic data, oocyte donation cycle outcomes, embryo transfer data, and pregnancy outcomes were obtained from the cohort of SCMIP. RESULTS: In total, 395 SCMIP had an initial consultation during the study period and 149 (37.7%) (23 single males, 126 male couples) underwent treatment. The mean age at initial consultation was 38.1 years; data over time show a trend towards initiating care at a younger age. One hundred and thirty-three fresh oocyte retrieval cycles, 51 frozen oocyte warming cycles, and 222 embryo transfers were performed. The mean number of embryos obtained per cycle was 8.0 (SD 5.7) in fresh oocyte donation cycles versus 3.3 (SD 2.5) in frozen oocyte donation cycles. The live birth rate per embryo transfer was similar when comparing fresh oocyte donation with frozen oocyte donation (55.4% versus 52.8%, respectively; P = 0.86). The use of preimplantation genetic testing for aneuploidy did not impact treatment success. Overall, after all cumulative embryo transfers via a gestational carrier in the study period, 87% of SCMIP achieved a live birth, with an average latency of 1.6 years between initial consultation and embryo transfer. CONCLUSION: This large data set of male patients illustrates that, despite the significant time and costs associated with the process, SCMIP are increasingly accessing ART to achieve fatherhood with good success.